William Blair Reaffirms “Outperform” Rating for Equifax (NYSE:EFX)

Equifax (NYSE:EFX)‘s stock had its “outperform” rating reiterated by research analysts at William Blair in a research report issued on Friday,RTT News reports.

EFX has been the topic of several other reports. Oppenheimer cut their price target on shares of Equifax from $315.00 to $286.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Morgan Stanley cut their price target on shares of Equifax from $320.00 to $316.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. BNP Paribas raised shares of Equifax from a “neutral” rating to an “outperform” rating and set a $305.00 price target for the company in a report on Monday, December 16th. Robert W. Baird upped their target price on shares of Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Wolfe Research lowered shares of Equifax from an “outperform” rating to a “peer perform” rating in a research report on Thursday, December 12th. Two analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $307.47.

Equifax Price Performance

Equifax stock traded down $0.07 during midday trading on Friday, reaching $247.41. The company had a trading volume of 70,059 shares, compared to its average volume of 987,182. The company has a market capitalization of $30.67 billion, a P/E ratio of 54.98, a P/E/G ratio of 2.84 and a beta of 1.58. Equifax has a 12-month low of $213.02 and a 12-month high of $309.63. The firm’s fifty day simple moving average is $261.38 and its 200-day simple moving average is $274.90. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.88 and a quick ratio of 0.88.

Equifax (NYSE:EFX) last announced its quarterly earnings results on Thursday, February 6th. The credit services provider reported $2.12 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.12. Equifax had a net margin of 10.07% and a return on equity of 18.56%. As a group, equities analysts anticipate that Equifax will post 7.27 EPS for the current year.

Insider Buying and Selling

In related news, EVP Lisa M. Nelson sold 551 shares of Equifax stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total value of $143,474.89. Following the completion of the sale, the executive vice president now owns 11,697 shares of the company’s stock, valued at approximately $3,045,781.83. This trade represents a 4.50 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.66% of the stock is owned by company insiders.

Institutional Trading of Equifax

Hedge funds have recently bought and sold shares of the company. McClarren Financial Advisors Inc. bought a new stake in Equifax in the fourth quarter worth $25,000. Ashton Thomas Securities LLC purchased a new stake in Equifax during the third quarter valued at $29,000. Central Pacific Bank Trust Division purchased a new stake in Equifax in the fourth quarter worth about $35,000. Spire Wealth Management increased its position in Equifax by 98.7% in the fourth quarter. Spire Wealth Management now owns 151 shares of the credit services provider’s stock worth $38,000 after buying an additional 75 shares in the last quarter. Finally, Exchange Traded Concepts LLC purchased a new stake in shares of Equifax during the third quarter worth about $48,000. Institutional investors own 96.20% of the company’s stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.